Cargando…
The development of a stochastic mathematical model of Alzheimer’s disease to help improve the design of clinical trials of potential treatments
Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by a slow progressive deterioration of cognitive capacity. Drugs are urgently needed for the treatment of AD and unfortunately almost all clinical trials of AD drug candidates have failed or been discontinued to date. Mathematica...
Autores principales: | Hadjichrysanthou, Christoforos, Ower, Alison K., de Wolf, Frank, Anderson, Roy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788351/ https://www.ncbi.nlm.nih.gov/pubmed/29377891 http://dx.doi.org/10.1371/journal.pone.0190615 |
Ejemplares similares
-
A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers
por: Lawrence, Emma, et al.
Publicado: (2017) -
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
por: Ower, Alison K., et al.
Publicado: (2017) -
Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
por: Stylianou, Andria, et al.
Publicado: (2017) -
Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies
por: Hadjichrysanthou, Christoforos, et al.
Publicado: (2018) -
The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
por: Evans, Stephanie, et al.
Publicado: (2018)